Search Within

Andrew Joseph Plodkowski

  1. "GSK Faculty"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (14)
Groups
  1. Body Imaging Service (44)
  2. Department of Medicine (44)
  3. GSK Faculty (44)
  4. Radiology, Department of (44)
  5. Solid Tumor Oncology Division (44)
  6. Thoracic Oncology (43)

More Groups

People
  1. Charles Rudin (32)
  2. Mark Kris (25)
  3. Gregory Riely (23)
  4. Marc Ladanyi (22)
  5. Matthew Hellmann (22)
  6. Hira Rizvi (17)

More People

Years
  1. 2024 (1)
  2. 2023 (7)
  3. 2022 (3)
  4. 2021 (2)
  5. 2020 (8)
  6. 2019 (8)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Clinical Cancer Research (8)
  3. Journal of Thoracic Oncology (8)
  4. Annals of Oncology (4)
  5. Cancer Cell (2)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (11)
  3. Elsevier Inc. (9)
  4. Oxford University Press (5)
  5. Cell Press (2)
  6. Biomed Central Ltd (1)

More Publishers

Results (44)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas
    Journal Article

    Rekhtman, N.; Montecalvo, J.; Chang, J. C.; Alex, D.; Ptashkin, R. N.; Ai, N.; Sauter, J. L.; Kezlarian, B.; Jungbluth, A.; Desmeules, P.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • A phase 2 trial of cabozantinib in ROS1-rearranged lung adenocarcinoma
    Meeting Abstract

    Guo, R.; Preeshagul, I.; Schoenfeld, A.; McCarthy, C.; Makhnin, A.; Plodkowski, A.; Ginsberg, M.; Davare, M.; Delasos, L.; Somwar, R.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
    Journal Article

    Hastings, K.; Yu, H. A.; Wei, W.; Sanchez-Vega, F.; DeVeaux, M.; Choi, J.; Rizvi, H.; Lisberg, A.; Truini, A.; Lydon, C. A.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of ramucirumab and docetaxel given either before or after immune checkpoint inhibitors in patients with lung cancers
    Meeting Abstract

    Offin, M.; Xu, C.; Jain, H.; Makhnin, A.; Hayes, S. A.; Plodkowski, A. J.; Halpenny, D.; Rudin, C. M.; Kris, M. G.; Drilon, A. E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
    Meeting Abstract

    Paik, P. K.; Ahn, L. S. H.; Ginsberg, M. S.; Plodkowski, A. J.; Kim, R.; Doyle, L. A.; Rudin, C. M.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Real-world experience and molecular features of response to immune checkpoint blockade in patients with recurrent small cell lung cancer
    Meeting Abstract

    Lai, W. C. V.; Rizvi, H.; Egger, J. V.; Plodkowski, A. J.; Ginsberg, M. S.; Kris, M. G.; Beras, A.; Rekhtman, N.; Poirier, J. T.; Hellmann, M. D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Acquired MET exon 14 alteration drives secondary resistance to epidermal growth factor receptor tyrosine kinase inhibitor in EGFR-mutated lung cancer
    Journal Article

    Suzawa, K.; Offin, M.; Schoenfeld, A. J.; Plodkowski, A. J.; Odintsov, I.; Lu, D.; Lockwood, W. W.; Arcila, M. E.; Rudin, C. M.; Drilon, A.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Acquired BRAF rearrangements induce secondary resistance to EGFR therapy in EGFR-mutated lung cancers
    Journal Article

    Vojnic, M.; Kubota, D.; Kurzatkowski, C.; Offin, M.; Suzawa, K.; Benayed, R.; Schoenfeld, A. J.; Plodkowski, A. J.; Poirier, J. T.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: A retrospective international multicentre study
    Journal Article

    Lai, W. V.; Lebas, L.; Barnes, T. A.; Milia, J.; Ni, A.; Gautschi, O.; Peters, S.; Ferrara, R.; Plodkowski, A. J.; Kavanagh, J.; more...
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Clinical and molecular features predicting long-term response (LTR) to anti-PD-(L)1 based therapy in patients with NSCLC
    Meeting Abstract

    Rizvi, H.; Plodkowski, A. J.; Tenet, M.; Halpenny, D.; Long, N.; Sauter, J. L.; Sanchez-Vega, F.; Chatila, W. K.; Schultz, N.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save